Mechanisms of resistance to NAMPT inhibitors in cancer
{{output}}
A common barrier to the development of effective anticancer agents is the development of drug resistance. This obstacle remains a challenge to successful clinical translation, particularly for targeted agents. Nicotinamide phosphoribosyltransferase (NAMPT) inh... ...
